| FDA APPROVALS Kybella (deoxycholic acid), a treatment for adults with moderate-to-severe fat below the chin The first generic Abilify to treat mental illnesses |
 |
Can Drug Companies Be Shamed into Limiting Price Hikes?
Hospitals & Health Networks - May 6, 2015
Threats to 340B, along with soaring pharmaceutical prices, are big concerns for hospitals, Ascension Health executives say.
How Much?! Global Spending on Cancer Medicines Hit $100B Last Year
Wall Street Journal - May 5, 2015
As concerns mount over outlays for prescription drugs, a new report finds that global spending on oncology treatments reached $100 billion last year, which represented a 10.3% increase from the previous year and a substantial rise from $75 billion spent five years ago.
Contrary to goals, ER visits rise under Obamacare
USA TODAY - May 4, 2015
Three-quarters of emergency physicians say they've seen ER patient visits surge since Obamacare took effect — just the opposite of what many Americans expected would happen.
Glaxo becomes first big pharma to file for a gene therapy approval
BioPharma Dive - May 5, 2015
GlaxoSmithKline on Tuesday became the first pharma giant to file for marketing authorization of a gene therapy, Reuters reports.
Gilead’s Gaffe Leads Drugmakers to Pledge More Openness on Price
Bloomberg - May 4, 2015
Drugmakers worried about a backlash over soaring drug prices are increasingly talking with insurers ahead of time about paying for new therapies that could cost six figures a year.
Can the new FDA guidance on biosimilarity expedite development and approval?
BioPharma Dive - April 30, 2015
Since the approval of Zarxio in March, the biosimilars race has been heating up. But one major challenge for all contenders has been a lack of clarity regarding the approval pathway.
FDA enforces new drug safety labeling system for pregnant women
Fox News - April 27, 2015
A new labeling system for prescription drugs will take effect in June, according to the U.S. Food and Drug Administration (FDA), marking a radical change in the information available to doctors when prescribing medications to pregnant patients.
Merck Gains Edge on Rivals With Results About its Diabetes Drug
Wall Street Journal - Apr 28, 2015
In a big boost for Merck, the drug maker late yesterday disclosed positive news about a long-awaited clinical trial that was designed to test the safety of its best-selling Januvia diabetes tablet.
With Sickest Patients, Cost Sharing Comes at a Price
New York Times - May 4, 2015
The growth in health care spending is slowing down, and one reason might be that cost sharing is rising.
A gram of prevention: Providers urged to go metric to avoid medication errors
Modern Healthcare - May 1, 2015
Miscalculated drug dosages because of confusion when patients' weights are converted from pounds to kilograms are common and can result in patients' receiving potentially fatal overdoses. These errors persist despite years of adverse incidents, warnings and recommended fixes, patient-safety experts say.
Study Casts Doubt on Use of Common Antibiotic for UTIs in Women
HealthDay News - April 30, 2015
The antibiotic most commonly prescribed for bladder and other urinary tract infections, nitrofurantoin, may not be the most effective option, new research suggests.
Medicare Part D Should be Allowed to Obtain More Rebates for Drugs: Study
Wall Street Journal - Apr 28, 2015
A new report is encouraging the Centers for Medicare & Medicaid Services and Congress to pursue additional rebates for prescription drugs purchased for the Medicare Part D program.
Metformin Rarely Prescribed to Prevent Diabetes
Pharmacy Times - May 5, 2015
Although metformin can help prevent diabetes onset in those at high risk, the medication is rarely prescribed for this purpose.
Contact,
Jan Tankersley
Senior Vice President, Marketing & Sales
Pharmaceutical Strategies Group (PSG)
Office: 972-943-7141
Email: JTankersley@PSGConsults.com
PSGNewsletter@PSGConsults.com
www.PSGConsults.com
 |
 |
 |